Succession

Right content, wrong person

How to map your content to your buyers and your sales stages, find the gaps, and decide what to build first

By Jess Evans · 5 min read

Right content, wrong person

How to map your content to your buyers and your sales stages, find the gaps, and decide what to build first

Author

Jess Evans
November 22, 2026

Read time: 5 minutes

Welcome to the Succession newsletter where 2,000+ life science sales reps improve their skills in 5 minutes per week. If you’re getting value from these newsletters, we'd love it if you could forward it along to your sales colleagues. If you’re new here, subscribe below.

Succession Bio works with life science/biotech companies to help drive sales, licensing, and partnership opportunities.

We do this through market research to identify the right companies and people, craft scientifically credible messages, and then perform the outbound sales and marketing tactics on your behalf to facilitate meetings with the right people at the right companies.

Succession

  • Specializes in life sciences/biotech (it's all we do!)

  • Provides market research, messaging, and outbound sales/marketing services

  • Facilitates meetings and opportunities with the right people at the right companies for our clients

  • Sales training for teams of 10+ who want to find and close more deals with biotech and pharma

Before we get started, a quick reminder we’re currently running a webinar series on applying AI to life sciences GTM. Our next session is Dec 3rd, where we’ll cover buying signals, how to automate finding them and acting on them in a way that gets responses and doesn’t just sound like a generic “congrats on the raise” outreach. You can see the series and register here.

Right onto the newsletter….

If you sell into biotech and pharma (hopefully all of you reading this, or you may be in the wrong place), you probably have more content than you think.

Somewhere on a shared drive there's a white paper from 2017 that is still completely accurate. There are three posters from conferences nobody remembers going to, an app note someone in marketing spent a month on, and a brochure that gets attached to every email whether it fits or not.

None of that is wasted effort. Someone did good science and wrote it up properly, which is more than most companies manage. What's usually missing is a decision about who each piece is for, and when they should see it.

The same decision applies to the early teams who’ve just started to build out their sales and marketing collateral as they make the shift from “all our sales come from our network” to “we need to get our name out there and build pipeline with more people than the ones our founders are mates with”.

A few weeks ago we were on a call with a client, a CRO with a brilliant research team. They'd put together a slide of content ideas for next year. It was a good list. LinkedIn posts. A white paper. App notes. A video. And my personal favourite: "Cartoon?" (question mark included, which I respect).

Then we asked who it was all for.

Their head of sales pulled up a graph he'd drawn late one evening. Customer technical understanding up one side, sales stage along the bottom, and dots scattered all over it. At one end, someone whose ChatGPT had told them a specific screen would be great for their project. At the other, a person who runs a specialist group at a top-ten pharma and knows more about it than most vendors do. Both send the same enquiry email. Both ask for "a quick call to discuss pricing".

I recognised this scenario straight away. At my last job, at a specialist C. elegans CRO, our buyers were worm people or non-worm people. The worm people wanted strain backgrounds and minute assay condition details. The non-worm people wanted to know if their drug slowed down disease progression. Same service, completely different conversation, so you can’t just send them both the same pdf.

So this week that’s what we’re going to tackle: how to map your content against who is buying and where they are in the sales process, spot the gaps, and work out what to build first. Grab a coffee and open a LLM chat, a spreadsheet (if you wanna do this old school), or your phone notes app if you’re reading this on the go.

Why one piece of content can't do every job

Two things decide what a piece of content needs to be.

  1. Who is reading it. A buyer who knows the goal and a buyer who knows the method need different detail, different language and different proof.

  1. When they're reading it. Someone who has never heard of you needs a reason to reply. Someone comparing two quotes needs a spec sheet and some data.

Cross those two and you get the settings for every piece: how technical it is, how much it teaches, and whether it leads with the outcome, the method, the process or the product.

Most content libraries are sorted by only one thing, usually product. One brochure per service, one app note per technology. Then a rep sends the specialist app note to a CSO who only wanted to know if the study would answer their question, and wonders why the thread went quiet.

Step 1: Name your buyer groups

Ask a sales team who their buyers are and you'll get eight personas, a Venn diagram and a long silence. Start smaller. For most technical products and services, buyers split into two groups based on what they already know.

The goal-led buyer: knows the goal, not the method.

  • Who: CSO, head of biology, a programme lead. Often at a small or mid-size biotech.

  • What they say: "We need to know which indication to go into next." "Why do tumours stop responding to our drug?"

  • What they need: what the work will answer, what they get back, how long it takes, what good looks like.

  • What loses them: your platform name, product specs, anything that reads like a methods section.

The specialist buyer: knows the method, arrives with a design in mind.

  • Who: head of screening, functional genomics lead, pharmacology or computational biology lead. Often inside pharma.

  • What they say: "Pooled knockout, whole genome, 500-fold coverage, in this cell line."

  • What they need: exactly how you do it, in their terms, and where it differs from how they'd do it themselves or with another provider.

  • What loses them: being told what the technique is and what it’s outcome is. They've been doing it for ten years, they already know what questions it answers they just need to know why your way is better.

Specialists trust you when you show your working. We heard a great example of this recently. A customer asks for 500-fold coverage. The provider runs at 300-fold, so it looks like a shortfall. But the provider runs two replicates, so in the customer's terms it's actually 600. Nobody had ever told them. One sentence in a "how we run it" document fixes that before it becomes an objection.

Here's the same service written for each buyer. Say you sell a liver organoid toxicity service:

  • Goal-led: "Find out which of your candidates is going to hurt the liver before your rat study does."

  • Specialist: "Human iPSC-derived liver organoids, 14-day repeat dosing, albumin, urea and ALT readouts, with every run benchmarked against a reference compound set."

Both are true. Same service, different reader.

One more split worth knowing. Biotech or pharma is a separate question from goal-led or specialist. At a small biotech you can read the pipeline page and see the indication. Inside a big pharma oncology group, a job title rarely tells you which cancer someone works on. So the segment decides how you find someone, and the buyer type decides how you write to them. A biotech CSO who used to run screens is a specialist. A pharma programme lead who has never run one is goal-led.

Your template. For each buyer group, write down:

  1. Who they are (titles and company type)

  2. The first thing they say when they get in touch (copy real enquiry emails word for word)

  3. What they need to believe before they'll take the next step

  4. What convinces them: a story, a number, a dataset, or a peer who's done it

  5. What makes them switch off

  6. Quick win: your inbox already knows the answers. Ask your AI tool of choice to go through every email your sales team has sent to your in-house scientists and pull out the technical questions. That's your specialist FAQ, written by your customers. Then do the same with your inbound enquiries to see how each group describes its problem in its own words.

Step 2: Map your sales stages, and what content has to do at each one

Here's the sales process most of our clients run, with the job content has to do at each stage.

1. Cold outbound. They've never heard of you. Content's job: earn a reply by saying something true about their work. Lead with: the application and the outcome.

2. First reply or inbound enquiry. They've asked a question, or named a technique. Content's job: set the level so the conversation starts in the right place. Lead with: the technology. What it can tell them and what it can't.

3. Before the discovery call. A call is booked. The scope is fuzzy. Content's job: get them thinking about their own design before they turn up. Lead with: the process. The variables, the choices, the timeline.

4. The discovery call. You're talking. Content's job: give you something to show, as well as tell. Lead with: their question, mapped to work you've already done.

5. Follow-up and project design. A scientist is involved and options are on the table. Content's job: make the choice between options clear, with the data behind every claim. Lead with: the product and the proof. Specs, example data, case studies.

6. Proposal and closing. Procurement, sign-off, someone senior asking "why this?" Content's job: help your champion sell it internally. Lead with: the business case, the timeline and the risk of doing nothing.

7. Not ready. Real interest, wrong moment. This is where most of your pipeline sits. Content's job: stay useful without asking for anything. Lead with: the topic. What's happening in their field, with your work visible in it.

Two things in there surprise people.

Outbound and inbound want opposite things. In outbound, lead with the application. Someone working on combination strategies doesn't care what you call your platform. They care whether you can tell them what to combine with. But when an enquiry comes in naming a technology ("can you send pricing for a CRISPR screen?"), send technology content. If they asked about the method and you send them a lovely piece about target ID, it looks like you didn't read their email.

Stage 3 is where your experts' time leaks. Every technical company I've worked with has a handful of senior scientists who win deals when they join a call. So everyone wants them on every call. They're busy, and putting them in front of someone who hasn't worked out what they want yet costs them an afternoon and you some goodwill. The fix is a bit of homework before you bring in the big brains.

Here's the email. Have your scientists write the questions once, and sales can send it forever.

Subject: Before we talk on Thursday

Hi [Name],

Thanks for getting in touch about [technique]. Looking forward to our discussion on Thursday.

So we can make the most of the time (and so I bring the right scientist), it would really help to have your rough thoughts on a few questions. Bullet points are perfect:

  1. What question are you trying to answer with this work?

  2. What decision will the results feed into, and roughly when?

  3. What model or system are you working in currently?

  4. Have you run anything like this before, in-house or with another partner?

  5. What would a great result look like for you?

If it's useful for anyone else joining, here's a short guide to what [technique] can and can't tell you: [link]

Thanks, [Your name]

It does three jobs at once. The goal-led buyer gets a structure for their thinking and shows up prepared. The specialist sees straight away that you know which questions matter. And your scientist walks in knowing exactly who they're talking to.

Step 3: Build the grid and find your gaps

Make a grid. Sales stages down the side, buyer groups across the top. Then put every piece of content you already own into a box.

Be honest here. If the sales team never actually sends something, it still goes in the box it was meant for, with a note that says "nobody uses this".

Here's what we usually find when we do this with clients:

  • Stage 5, specialist is packed. App notes, posters, white papers, spec sheets, all of it.

  • Stage 1 has one brochure that tries to talk to everyone.

  • Stages 2 and 3, goal-led are empty. That's the "nothing in between" gap, and it's exactly where your scientists' time goes.

  • Stage 7 has nothing, or a newsletter that only announces products. (Ahem. Not this one.)

Every empty box is a gap, but not every gap needs filling. Some boxes barely matter for how your business makes money. Which brings us to the fun bit.

Before you move on, look again at that 2017 white paper. Old content that's still accurate is a gift. One poster can become three LinkedIn posts, a short explainer for stage 2 and a page on your website. You don't need to write everything from scratch.

Step 4: Decide what to build first

Score each gap from 1 to 3 on these four questions, add them up, and build the top three.

1. Which buyer converts best for you? Ask your reps: if you had ten conversations with each type of buyer, how many would go forward, and how big would they be? Anecdote is fine. Your CRM probably can't tell you anyway. Start with whichever buyer makes you the most money.

2. Where do your deals stall? If people go quiet after the first reply, you need stage 2 content. If they go quiet after the discovery call, you need stage 5. Your pipeline will tell you if you look at where things stop.

3. Where does your most expensive time go? If your senior scientists spend hours on calls explaining the basics, stage 2 and 3 content for goal-led buyers pays back fast. It's the cheapest way to get more of their time back.

4. What can you build from what you already have? A piece cut from an existing poster, or from a 30-minute interview with your scientist, takes days. A new white paper from scratch takes a lot longer. Speed counts.

Then build one anchor piece and cut it down. One interview with your lead scientist can become:

  • a "what this technique can and can't tell you" guide (stage 2)

  • the pre-call question sheet (stage 3)

  • a handful of LinkedIn posts (stage 7)

  • a few short video clips your reps can send (stages 1 and 7)

Tip: run the interview with an AI interviewer. Your scientist answers questions out loud for half an hour and never has to write a word. That's the only way some of them will ever say yes.

The one-hour version

If you only do one thing this month, do this:

  • 5 minutes: write down your two buyer groups using the template above.

  • 10 minutes: list every piece of content you have and drop it into the grid.

  • 10 minutes: ask two reps which buyer converts best and where deals stall.

  • 5 minutes: score the empty boxes and pick your top three.

  • 30 minutes: book a 30-minute interview with your best scientist. That one recording can fill three of those boxes.

And if your content plan currently says "Cartoon?", keep it. Just decide who it's for and when they get it.

Jess

  1. Lead Generation: We’ll build target lists, write scientifically relevant messaging, and send messages on your behalf to book qualified sales meetings with biotech and pharma companies.

  2. Training for Teams: If you want to upskill your team around prospecting, driving to close, key account management, AI, or any other topic, we can put together a training plan specific to your organization’s needs.

  3. Strategy Call: Need more than training? Want help implementing and executing your sales strategy? In a 30-minute call, we will assess your company’s current situation and identify growth opportunities.